Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Cefotaxime

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 110Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    13/04/2020 Kopran
    India
    		 Kopran Research Laboratories Limited WC-0090 Cefotaxime Sodium (EP/USP) 2022-08-31 2025-07-14 K4/4, Additional MIDC, Bivwadi, Taluk Mahad, Dist Raigad-402302, Maharashtra, India
    01/01/2018 Nectar Lifesciences
    India
    		 M/s. Nectar Lifesciences Ltd WC-0145 Cefotaxime Sodium (Sterile) (USP/BP/Ph. Eur.) 2016-09-06 2019-07-02 Village- Saidpura,Tehsil-Derabassi, District-Mohali (Punjab) India-140 507